Literature DB >> 11352291

Diagnosis and treatment of pulmonary hypertension.

T D Nauser1, S W Stites.   

Abstract

Primary pulmonary hypertension is a rare disease of unknown etiology, whereas secondary pulmonary hypertension is a complication of many pulmonary, cardiac and extrathoracic conditions. Chronic obstructive pulmonary disease, left ventricular dysfunction and disorders associated with hypoxemia frequently result in pulmonary hypertension. Regardless of the etiology, unrelieved pulmonary hypertension can lead to right-sided heart failure. Signs and symptoms of pulmonary hypertension are often subtle and nonspecific. The diagnosis should be suspected in patients with increasing dyspnea on exertion and a known cause of pulmonary hypertension. Two-dimensional echocardiography with Doppler flow studies is the most useful imaging modality in patients with suspected pulmonary hypertension. If pulmonary hypertension is present, further evaluation may include assessment of oxygenation, pulmonary function testing, high-resolution computed tomography of the chest, ventilation-perfusion lung scanning and cardiac catheterization. Treatment with a continuous intravenous infusion of prostacyclin improves exercise capacity, quality of life, hemodynamics and long-term survival in patients with primary pulmonary hypertension. Management of secondary pulmonary hypertension includes correction of the underlying cause and reversal of hypoxemia. Lung transplantation remains an option for selected patients with pulmonary hypertension that does not respond to medical management.

Entities:  

Mesh:

Year:  2001        PMID: 11352291

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  25 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

Review 3.  Assessment of pulmonary hypertension by CT and MR imaging.

Authors:  Sebastian Ley; Karl-Friedrich Kreitner; Christian Fink; Claus P Heussel; Mathias M Borst; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

4.  Potential of right to left ventricular volume ratio measured on chest CT for the prediction of pulmonary hypertension: correlation with pulmonary arterial systolic pressure estimated by echocardiography.

Authors:  Heon Lee; Seok Yeon Kim; Soo Jeong Lee; Jae Kyun Kim; Ryan P Reddy; U Joseph Schoepf
Journal:  Eur Radiol       Date:  2012-04-27       Impact factor: 5.315

5.  P-selectin gene polymorphism associates with pulmonary hypertension in congenital heart disease.

Authors:  Xiao-Fei Li; Chun-Hui Song; Hong-Zhuan Sheng; Dong-Dong Zhen; Min Pan; Jian-Hua Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.

Authors:  Birgit Houweling; Daphne Merkus; Oana Sorop; Frans Boomsma; Dirk J Duncker
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

7.  Patient-specific computational modeling of blood flow in the pulmonary arterial circulation.

Authors:  Vitaly O Kheyfets; Lourdes Rios; Triston Smith; Theodore Schroeder; Jeffrey Mueller; Srinivas Murali; David Lasorda; Anthony Zikos; Jennifer Spotti; John J Reilly; Ender A Finol
Journal:  Comput Methods Programs Biomed       Date:  2015-04-28       Impact factor: 5.428

Review 8.  Pulmonary arterial hypertension: an imaging review comparing MR pulmonary angiography and perfusion with multidetector CT angiography.

Authors:  F P Junqueira; C M A O Lima; A C Coutinho; D B Parente; L K Bittencourt; L G P Bessa; R C Domingues; E Marchiori
Journal:  Br J Radiol       Date:  2012-08-29       Impact factor: 3.039

9.  Optimization Framework for Patient-Specific Cardiac Modeling.

Authors:  Joshua Mineroff; Andrew D McCulloch; David Krummen; Baskar Ganapathysubramanian; Adarsh Krishnamurthy
Journal:  Cardiovasc Eng Technol       Date:  2019-09-17       Impact factor: 2.495

10.  Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI.

Authors:  Sebastian Ley; Michael Puderbach; Christian Fink; Monika Eichinger; Christian Plathow; Susanne Teiner; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2005-03-11       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.